CLSI M33-A

Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard, M33AE

Clinical and Laboratory Standards Institute, 02/01/2004

Publisher: CLSI

File Format: PDF

$120.00$240.30

Description

Published:01/02/2004

Pages:39

This document provides a protocol for the performance of the plaque reduction assay for phenotypic antiviral susceptibility testing of herpes simplex virus.

More CLSI standard pdf

CLSI QMS20-R

Understanding the Cost of Quality in the Laboratory; A Report, QMS20RE

$90.00 $180.00

CLSI M29-A4

Protection of Laboratory Workers from Occupationally Acquired Infections; Approved Guideline - Fourth Edition, M29A4E

$90.00 $180.00

CLSI H60-A (R2019)

Laboratory Testing for the Lupus Anticoagulant; Approved Guideline, H60AE

$90.00 $180.00

CLSI H52-A2 (R2016)

Red Blood Cell Diagnostic Testing Using Flow Cytometry; Approved Guideline - Second Edition, H52A2E

$90.00 $180.00